Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-to-severe Inflammatory Bowel Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01576471
What this trial is testing

Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo

Who this might be right for
Crohn's Disease
Coronado Biosciences, Inc. 250
Large-scale testing (Phase 3)Looking for participantsNCT07185009
What this trial is testing

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Sanofi 751
Testing effectiveness (Phase 2)Ended earlyNCT03635112
What this trial is testing

Efficacy and Safety of TD-1473 in Crohn's Disease

Who this might be right for
Crohn's Disease
Theravance Biopharma 167
Post-approval studies (Phase 4)Looking for participantsNCT07235904
What this trial is testing

Efficacy of Top-down Therapy With Mirikizumab Versus Standard of Care With Azathioprine in Patients With Newly Diagnosed Moderate-to-severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)
University Hospital Schleswig-Holstein 300
Large-scale testing (Phase 3)Ended earlyNCT02520284
What this trial is testing

Safety and Efficacy of Andecaliximab (GS-5745) in Adults With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Gilead Sciences 165
Testing effectiveness (Phase 2)Ended earlyNCT00038766
What this trial is testing

CNI-1493 for Treatment of Moderate to Severe Crohn's Disease

Who this might be right for
Crohn Disease
Ferring Pharmaceuticals 33
Large-scale testing (Phase 3)Study completedNCT01465763
What this trial is testing

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Pfizer 614
Early research (Phase 1)Study completedNCT06281704
What this trial is testing

AK101 in Subjects With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Akeso 34
Testing effectiveness (Phase 2)Study completedNCT02958865
What this trial is testing

Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Pfizer 319
Post-approval studies (Phase 4)Not Yet RecruitingNCT07665294
What this trial is testing

Combination CurQD and Vedolizumab in Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Ryan C Ungaro 160
Testing effectiveness (Phase 2)Study completedNCT02513459
What this trial is testing

A Long Term Extension Trial of BI 655066/ABBV-066 (Risankizumab), in Patients With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn Disease
AbbVie 65
Testing effectiveness (Phase 2)Ended earlyNCT02574637
What this trial is testing

Evaluation of Efficacy and Safety of Brazikumab (MEDI2070) in Participants With Active, Moderate to Severe Crohn's Disease

Who this might be right for
Crohn's Disease
AstraZeneca 29
Large-scale testing (Phase 3)Study completedNCT02611830
What this trial is testing

Efficacy and Safety of Vedolizumab Subcutaneously (SC) as Maintenance Therapy in Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Takeda 383
Testing effectiveness (Phase 2)Ended earlyNCT02405442
What this trial is testing

Safety and Efficacy of Andecaliximab in Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
Gilead Sciences 187
Large-scale testing (Phase 3)Ended earlyNCT02403323
What this trial is testing

Open-Label Extension and Safety Study for Participants With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144

Who this might be right for
Crohn Disease
Hoffmann-La Roche 790
Testing effectiveness (Phase 2)Study completedNCT05061446
What this trial is testing

Etrasimod Dose-Ranging Versus Placebo as Induction Therapy Study in Adult Japanese Subjects With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Pfizer 54
Post-approval studies (Phase 4)Study completedNCT05205603
What this trial is testing

Efficacy of Mesalazine Combined With Biologics in the Treatment of Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative ColitisEfficacy, SelfBiologics+1 more
Sixth Affiliated Hospital, Sun Yat-sen University 438
Testing effectiveness (Phase 2)Looking for participantsNCT06975722
What this trial is testing

Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Sanofi 99
Testing effectiveness (Phase 2)Ended earlyNCT01009281
What this trial is testing

An Open Label Safety and Tolerability Study of AIN457 in Patients With Moderate to Severe Crohn's Disease

Who this might be right for
Crohn's DiseaseInflammatory Bowel Disease
Novartis Pharmaceuticals 7
Testing effectiveness (Phase 2)Ended earlyNCT03844932
What this trial is testing

A Study Evaluating the Efficacy and Safety of ST-0529 in Subjects With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Sublimity Therapeutics Holdco Limited 235
Next Page